CervoMed Inc (NASDAQ:CRVO) has a beta value of 1.73 and has seen 13.0 million shares traded in the recent trading session. The company, currently valued at $33.51M, closed the recent trade at $4.06 per share which meant it gained $1.7 on the day or 72.03% during that session. The CRVO stock price is -549.75% off its 52-week high price of $26.38 and 55.67% above the 52-week low of $1.80. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.18 million shares traded. The 3-month trading volume is 240.89K shares.
The consensus among analysts is that CervoMed Inc (CRVO) is Buy stock at the moment, with a recommendation rating of 2.14. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.63.
CervoMed Inc (NASDAQ:CRVO) trade information
Sporting 72.03% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the CRVO stock price touched $4.06 or saw a fall of -56.15%. Year-to-date, CervoMed Inc shares have moved 73.50%, while the 5-day performance has seen it change 87.96%. Over the past 30 days, the shares of CervoMed Inc (NASDAQ:CRVO) have changed 85.39%. Short interest in the company has seen 0.9 million shares shorted with days to cover at 10.62.
Wall Street analysts have a consensus price target for the stock at $16.32, which means that the shares’ value could jump 75.12% from the levels at last check today. The projected low price target is $16.32 while the price target rests at a high of $16.32. In that case, then, we find that the latest price level in today’s session is -301.97% off the targeted high while a plunge would see the stock gain -301.97% from the levels at last check today.
CervoMed Inc (CRVO) estimates and forecasts
The company’s shares have lost -74.59% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 30.68%.
7 analysts offering their estimates for the company have set an average revenue estimate of 1.75M for the current quarter. 4 have an estimated revenue figure of 1.51M for the next ending quarter. Year-ago sales stood 2.49M and 2.35M respectively for this quarter and the next, and analysts expect sales will shrink by -29.84% for the current quarter and 30.68% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 73.43% over the past 5 years. Earnings growth for 2025 is a modest -127.35% while over the next 5 years, the company’s earnings are expected to decrease by -12.42%.
CRVO Dividends
CervoMed Inc is expected to release its next earnings report on 2024-Nov-11 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
CervoMed Inc (NASDAQ:CRVO)’s Major holders
Insiders own 35.20% of the company shares, while shares held by institutions stand at 18.15% with a share float percentage of 28.01%. Investors are also buoyed by the number of investors in a company, with CervoMed Inc having a total of 69.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF. As of Dec 31, 2024, the former fund manager holds about 3.10% shares in the company for having 255.64 shares of worth $1.0 million while later fund manager owns 134.39 shares of worth $0.53 million as of Dec 31, 2024, which makes it owner of about 1.63% of company’s outstanding stock.
